• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤利什曼病:氨苯砜在常见亚型中的治疗效果

Cutaneous Leishmaniasis: Therapeutic Efficacy of Dapsone in the Commonly Existing Sub-types.

作者信息

Dogra Jaideep, Lal Bhupender Behari, Misra Shyam Nath

出版信息

Indian J Dermatol Venereol Leprol. 1989 Nov-Dec;55(6):375-377.

PMID:28128121
Abstract

In India, contaneous leishmaniasis is confined to the western Thar desert. Epidemiologically, two different forms are seen, viz the rural and the urban forms. The vectors responsible for the transmission in this region are the Phlebotomus papatasi and the Sergentomyia clydei. The efficacy of oral dapsone was evaluated in the commonly existing sub-types of cutaneous leishmaniasis. Ten patients each of the nodular and ulcerative forms of cutaneous leishmaniasis were selected by strict 'clinical and pathological criteria and treated with oral dapsone in a dose of 2 mg per kg body weight daily, for 6 weeks. Seven patients of the nodular variety and all the ten patients in the ulcerative sub-group were cured. No major adverse effects were noted. Review after 6 months revealed no recurrence. in another ten patients taken as controls and not receiving the drug, the lesions showed no significant change.

摘要

在印度,皮肤利什曼病局限于西部塔尔沙漠地区。从流行病学角度来看,存在两种不同形式,即农村型和城市型。该地区负责传播的病媒是巴氏白蛉和克莱德司蛉。对口服氨苯砜在常见的皮肤利什曼病亚型中的疗效进行了评估。通过严格的“临床和病理标准,挑选出10例结节型和10例溃疡型皮肤利什曼病患者,每天按每公斤体重2毫克的剂量口服氨苯砜,治疗6周。结节型的7例患者和溃疡型亚组的所有10例患者均治愈。未观察到重大不良反应。6个月后复查未发现复发情况。另外10例作为对照未接受药物治疗的患者,其皮损无明显变化。

相似文献

1
Cutaneous Leishmaniasis: Therapeutic Efficacy of Dapsone in the Commonly Existing Sub-types.皮肤利什曼病:氨苯砜在常见亚型中的治疗效果
Indian J Dermatol Venereol Leprol. 1989 Nov-Dec;55(6):375-377.
2
Leishmaniasis and itraconazole: a controlled clinical trial on cutaneous subtypes.利什曼病和伊曲康唑:皮肤亚型的对照临床试验。
Int J Antimicrob Agents. 1994;4(4):309-11. doi: 10.1016/0924-8579(94)90031-0.
3
Dapsone in the treatment of cutaneous leishmaniasis.氨苯砜治疗皮肤利什曼病
Int J Dermatol. 1986 Jul-Aug;25(6):398-400. doi: 10.1111/j.1365-4362.1986.tb03435.x.
4
A double-blind study on the efficacy of oral dapsone in cutaneous leishmaniasis.
Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):212-3. doi: 10.1016/0035-9203(91)90025-t.
5
[Human leishmaniases in Morocco: a nosogeographical diversity].[摩洛哥的人类利什曼病:疾病地理学多样性]
Pathol Biol (Paris). 2011 Aug;59(4):226-9. doi: 10.1016/j.patbio.2009.09.003. Epub 2009 Nov 25.
6
Species composition of sand flies and bionomics of Phlebotomus papatasi and P. sergenti (Diptera: Psychodidae) in cutaneous leishmaniasis endemic foci, Morocco.摩洛哥皮肤利什曼病流行区白蛉的种类组成及巴氏白蛉和塞尔吉白蛉(双翅目:毛蠓科)的生物学特性
Parasit Vectors. 2016 Feb 2;9:60. doi: 10.1186/s13071-016-1343-6.
7
Ultrastructure study of experimental cutaneous leishmaniasis before and after Dapsone intake.氨苯砜摄入前后实验性皮肤利什曼病的超微结构研究
J Egypt Soc Parasitol. 1997 Aug;27(2):539-52.
8
Distribution, species composition and relative abundances of sandflies in North Waziristan Agency, Pakistan.巴基斯坦北瓦济里斯坦特区白蛉的分布、物种组成及相对丰度
Med Vet Entomol. 2016 Mar;30(1):89-94. doi: 10.1111/mve.12141. Epub 2015 Nov 19.
9
Detection, identification and molecular typing of Leishmania major in Phlebotomus papatasi from a focus of zoonotic cutaneous leishmaniasis in central of Iran.从伊朗中部一个动物源性皮肤利什曼病的焦点中,从白蛉属中检测、鉴定和分子分型出了利什曼原虫。
Exp Parasitol. 2010 Feb;124(2):232-7. doi: 10.1016/j.exppara.2009.10.004. Epub 2009 Oct 23.
10
Molecular detection of Leishmania infection in sand flies in border line of Iran-Turkmenistan: restricted and permissive vectors.在伊朗-土库曼斯坦边境的沙蝇中检测利什曼原虫感染:限制和许可的媒介。
Exp Parasitol. 2013 Oct;135(2):382-7. doi: 10.1016/j.exppara.2013.07.020. Epub 2013 Aug 6.

引用本文的文献

1
The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.控制和消除被忽视热带病的药物研发管道:2. 用于标签外使用的口服抗感染药物和药物组合。
Parasit Vectors. 2023 Oct 31;16(1):394. doi: 10.1186/s13071-023-05909-8.
2
Current therapies for treatment of cutaneous leishmaniasis in India.
Infection. 1992 Jul-Aug;20(4):189-91. doi: 10.1007/BF02033055.